Innovative companies are almost always on the radars of plenty of investors, and Kraig Biocraft Laboratories Inc. (OTC: KBLB), which is a leading spider silk fiber developer and innovator, was in the news cycle yesterday. On Wednesday, the company was in focus after it announced that it had managed to make a major breakthrough in its genetic research program.
The Breakthrough
In the news release yesterday, Kraig Biocraft Laboratories announced that its team of researchers had been successful in doubling the size and complexity of its spider silk gene insert package. The company went on to add that it was a major new milestone and would lead to significant advancements in material performance. It was another milestone for the company in its quest to develop advanced fibers after having already pioneered the production of recombinant spider silk not too long ago.
Key Details
Kraig Biocraft Laboratories noted yesterday in the announcement that the more complex and bigger gene insert packages had the potential to unlock higher quality material. The company went on to note that the breakthrough was further confirmation of its leadership position in the biomaterials innovations space.
CEO Quote
“We believe that larger and more complex gene insert packages hold the potential to unlock superior material characteristics in our spider silk fibers,” said Kim Thompson, CEO and Founder of Kraig Labs. “This breakthrough reinforces our leadership in biomaterials innovation and sets the stage for the next evolution of spider silk technology.”
Technicals
| +/- EMA(20) | 0.0929 (-2.80%) |
| +/- SMA(50) | 0.0947 (-4.65%) |
| +/- SMA(200) | 0.1039 (-13.09%) |
| 5-Day Perf. | -3.42% |
| 1-Month Perf. | -4.24% |
| 3-Month Perf. | +0.89% |
| 6-Month Perf. | -6.91% |
| YTD Perf. | -2.69% |
| 1-Year Perf. | -8.14% |
| RSI(14) | 43.69 |
| ATR(14) | 0.01 |
| ADX(14) | 32.68 |
| Beta (5Y) | 0.44 |
